Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

Study Summary

This is a multicenter, open label study designed to evaluate the safety, tolerability, and efficacy of topically administered VTR-297 solution. The efficacy objectives of the study will be assessed using fungal culture testing, Neutral Red Staining (NRS) microscopy examination, and KOH microscopy examination after 4 weeks of treatment with VTR-297.

Conditions

Onychomycosis of Toenail

Interventions / Drugs

Trichostatin A

View on ClinicalTrials.gov ↗

Sponsor

VNDA

Vanda Pharmaceuticals

Neuroscience

D38/100

Study Details

Enrollment50 participants

Primary Completion—

Lead SponsorVanda Pharmaceuticals

Data Retrieved2026-04-11 04:31:05.188703+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.